Welcome to eviQ
A free resource of evidence-based, consensus driven cancer treatment protocols and information for use at the point of care. eviQ is developed for the Australian context and supports health professionals in the delivery of cancer treatments.
Would you like us to provide a virtual education session to your team or department on the ADDIKD guideline implementation into eviQ protocols? Click through to request a session.
eviQ reference committee meetings will continue to be held virtually in 2023 with one face-to-face meeting per content area in the second half of the year. This follows the recent survey to all reference committee members.
eviQ has had another busy and productive year. We're proud to share eviQ's achievements for 2022 with you!
It's here! The The International Consensus Guideline for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) is published and available on eviQ. Watch the launch video for insights from the working group and development team.